Given these associations with Alzheimer’s disease and MS, and the known role of clusterin in multiple CNS pathologies, interrogating effects of clusterin on OPC function is useful for our understanding of how these cells may be affecting disease progression. This evidence concerns the gene CLU and early-onset autosomal dominant Alzheimer disease.